Publications by authors named "Martin Labuhn"

Claim this Profile
T
The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomas.
Jean-Louis Boulay, Mihai-Constantin S Ionescu, Balasubramanian Sivasankaran, Martin Labuhn, Béatrice Dolder-Schlienger

Int J Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.
Vincent Vuaroqueaux, Patrick Urban, Martin Labuhn, Mauro Delorenzi, Pratyaksha Wirapati

Breast Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples.
Rosanna Zanetti-Dällenbach, Vincent Vuaroqueaux, Edward Wight, Martin Labuhn, Gad Singer

Breast Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Patrick Urban, Vincent Vuaroqueaux, Martin Labuhn, Mauro Delorenzi, Pratyaksha Wirapati

J Clin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
Raoul Desbriere, Vincent Vuaroqueaux, Vincent Achard, Sandrine Boullu-Ciocca, Martin Labuhn

Obesity (Silver Spring)· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients.
Jonas Cicenas, Patrick Urban, Willy Küng, Vincent Vuaroqueaux, Martin Labuhn

Eur J Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.
Jonas Cicenas, Patrick Urban, Vincent Vuaroqueaux, Martin Labuhn, Willy Küng

Breast Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis